CTXR - CIK 0001506251
Citius Pharmaceuticals, Inc. has filed 625 documents with the SEC between 2010 and 2026. The most frequent type is major company event (181 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Securities registration | S-3 | 2026-05-22 | - |
| Major company event | 8-K | 2026-05-15 | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-15 | 2026-03-31 |
| Major company event | 8-K | 2026-05-08 | 2026-05-04 |
| Major company event | 8-K | 2026-04-29 | 2026-04-23 |
| Major company event | 8-K | 2026-04-24 | 2026-04-23 |
| Prospectus supplement | 424B5 | 2026-04-24 | - |
| Major company event | 8-K | 2026-04-06 | 2026-04-06 |
| Major company event | 8-K | 2026-03-31 | 2026-03-31 |
| Major company event | 8-K | 2026-03-10 | 2026-03-10 |
| Major company event | 8-K | 2026-03-04 | 2026-03-04 |
| Annual report to shareholders | ARS | 2026-02-24 | 2025-09-30 |
| Proxy materials | DEFA14A | 2026-02-24 | - |
| Proxy statement | DEF 14A | 2026-02-24 | 2026-04-06 |
| SCHEDULE 13G/A | - | 2026-02-17 | - |
| Major company event | 8-K | 2026-02-13 | 2026-02-09 |
| Quarterly report | 10-Q | 2026-02-13 | 2025-12-31 |
| Annual report (amended) | 10-K/A | 2026-01-28 | 2025-09-30 |
| Major company event | 8-K | 2025-12-23 | 2025-12-23 |
| Annual report | 10-K | 2025-12-23 | 2025-09-30 |
| SCHEDULE 13D/A | - | 2025-12-17 | - |
| Major company event | 8-K | 2025-12-01 | 2025-12-01 |
| SCHEDULE 13G | - | 2025-10-27 | - |
| Major company event | 8-K | 2025-10-23 | 2025-10-23 |
| Major company event | 8-K | 2025-10-21 | 2025-10-20 |
| Prospectus supplement | 424B5 | 2025-10-21 | - |
| Insider trade | 4 | 2025-09-23 | 2025-08-08 |
| SCHEDULE 13D/A | - | 2025-09-12 | - |
| Insider trade | 4 | 2025-08-12 | 2025-08-08 |
| Major company event | 8-K | 2025-08-12 | 2025-08-12 |
| Quarterly report | 10-Q | 2025-08-12 | 2025-06-30 |
| SCHEDULE 13D/A | - | 2025-07-25 | - |
| Major company event | 8-K | 2025-07-08 | 2025-07-07 |
| Major company event | 8-K | 2025-06-12 | 2025-06-09 |
| Prospectus supplement | 424B5 | 2025-06-11 | - |
| Major company event | 8-K | 2025-06-09 | 2025-06-09 |
| Major company event | 8-K | 2025-06-03 | 2025-06-02 |
| Major company event | 8-K | 2025-05-30 | 2025-05-29 |
| Major company event | 8-K | 2025-05-14 | 2025-05-14 |
| Quarterly report | 10-Q | 2025-05-14 | 2025-03-31 |
| Proxy materials | DEFA14A | 2025-04-28 | - |
| Proxy statement | DEF 14A | 2025-04-28 | 2025-06-09 |
| PRE 14A | - | 2025-04-18 | 2025-04-18 |
| Major company event | 8-K | 2025-04-18 | 2025-04-16 |
| Major company event | 8-K | 2025-04-03 | 2025-03-28 |
| Major company event | 8-K | 2025-04-02 | 2025-04-01 |
| Prospectus supplement | 424B5 | 2025-04-02 | - |
| Major company event | 8-K | 2025-03-10 | 2025-03-10 |
| Major company event | 8-K | 2025-02-14 | 2025-02-14 |
| Quarterly report | 10-Q | 2025-02-14 | 2024-12-31 |